|
Protocol Number:
87-CC-0091
- Title:
Nuclear Magnetic Resonance Imaging/Spectroscopy at 1.5 and 3.0 Tesla
- Number:
87-CC-0091
- Summary:
Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) are diagnostic tests that allow researchers to look at different chemical properties of tissue. Magnetic resonance imaging and spectroscopy studies can be used to gather or evaluate information about various aspects of patient's bodies or to monitor changes in the biochemistry and physiology of patient's bodies.
Unlike other diagnostic techniques (CT scan and PET scan) MRI and MRS do not use ionizing radiation. Some studies have shown that MRI is more effective at distinguishing normal parts of the anatomy from abnormal anatomy, especially in the brain. MRI has become the diagnostic test of choice for evaluating patient with multiple sclerosis.
The purpose of this study is to evaluate normal volunteers and patients with a variety of diseases with magnetic resonance imaging. Researchers will attempt different magnetic resonance imaging methods and techniques as well as different levels of magnetic strength.
- Sponsoring Institute:
-
National Institutes of Health Clinical Center (CC)
- Recruitment Detail
- Type:
Participants currently recruited/enrolled
- Gender:
Male & Female
- Referral Letter Required:
No
- Population Exclusion(s):
None
- Eligibility Criteria:
INCLUSION CRITERIA:
All patients undergoing MRI in the Clinical Center.
Patients must be able to provide informed consents.
EXCLUSION CRITERIA:
No contraindications to MRI.
Inability to understand consent form or consent process and the absence of a suitable guardian.
Refusal to Participate.
- Special Instructions:
Currently Not Provided
- Keywords:
-
Surface Coils
-
T1-Weighted Images
-
T2-Weighted Images
-
Pulse Sequences
-
Spin Echo
-
Inversion Recovery
-
Partial Saturation
-
GRASS
- Recruitment Keyword(s):
-
None
- Condition(s):
-
Healthy
- Investigational Drug(s):
- None
- Investigational Device(s):
- None
- Intervention(s):
- None
- Supporting Site:
- Warren G. Magnuson Clinical Center
- Contact(s):
-
Patient Recruitment and Public Liaison Office
Building 61 10 Cloister Court Bethesda, Maryland 20892-4754 Toll Free: 1-800-411-1222 TTY: 301-594-9774 (local),1-866-411-1010 (toll free) Fax: 301-480-9793 Electronic Mail:prpl@mail.cc.nih.gov
- Citation(s):
-
Nuclear magnetic resonance imaging in oncology
-
Surface coil proton MR imaging at 2 TE
-
Cyclosporin-Anephroxity and acute cellular rejection in renal transplant recipients: correlation between radionuclide and histologic findings
If you have:
Search The Studies | Help | Questions | Clinical Center Home | NIH Home
National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 01/30/2009
|
|